HPV Vaccine Cervarix Approved In Australia, GSK Says
Main Category: Cervical Cancer / HPV VaccineAlso Included In: Pediatrics / Children's Health; Women's Health / Gynecology
Article Date: 24 May 2007 - 6:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
GlaxoSmithKline on Monday announced that the Australian Therapeutic Goods Administration has approved its human papillomavirus vaccine Cervarix for girls and women ages 10 to 45, Reuters reports (Potter/Hirschler, Reuters, 5/21). According to Dow Jones, the approval is the first "major market" license for Cervarix. GSK also has applied for approval of the vaccine in the U.S. and Europe (Berton, Dow Jones, 5/21).
Cervarix and Merck's HPV vaccine Gardasil have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases. Researchers in a 2006 study published in the online edition of the Lancet also found that Cervarix prevented infection with HPV strains 31 and 45, which together with strains 16 and 18 cause more than 80% of cervical cancer cases. GSK in January announced that it would begin a trial to determine whether Cervarix provides better protection against cervical cancer than Gardasil (Kaiser Daily Women's Health Policy Report, 4/24).
"The approval of Cervarix in Australia is a key milestone towards eradicating the burden of cervical cancer for all women, especially as this is the first cervical cancer vaccine that is explicitly indicated anywhere in the world for women over the age of 26," Jean Stephenne, president of GlaxoSmithKline Biologicals, said (GSK release, 5/21). According to GSK, older women who already have HPV also could benefit from the vaccine because they are still at risk of contracting different strains. The company has applied to Australia's Pharmaceutical Benefits Advisory Council to include Cervarix on the national immunization list (Kaiser Daily Women's Health Policy Report, 4/24).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/71802.php>
APA
http://www.medicalnewstoday.com/releases/71802.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




